FOR THE MEDICAL PRACTITIONER

Oncology

doi: 10.25005/2074-0581-2025-27-3-764-775
ROLE OF RADIATION THERAPY IN COMBINED AND MULTIMODAL TREATMENT OF T3-4N1-2-3M0-1-2 STAGE SKIN CANCER

M.B. SAYFUTDINOVA1, D.Z. ZIKIRYAKHODZHAEV2, SH.K. NAZAROV3

1Department of Roentgenology and Radiology, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
2Association of Directors of Oncology and Radiology Centers and Institutes of the CIS, Moscow, Russian Federation
3Department of Surgical Diseases No. 1 named after Akademician K.M. Kurbоnov, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan

Objective: To evaluate the effectiveness of radiation therapy in the comprehensive treatment of cutaneous late-stage cancer (LSC).

Methods: This study analyzes the treatment outcomes of 522 patients with skin cancer, categorized as T3-4N1-2-3M0-1-2, who were registered and treated at the Republican Oncology Research Center in Dushanbe, Tajikistan. The locations of the cancer were as follows: head and neck – 440 patients (84.3%), trunk – 47 patients (9.0%), upper limbs – 26 patients (5.0%), and lower limbs – 9 patients (1.7%). Morphological examinations revealed the presence of squamous cell carcinoma in 340 patients (65.1%). Among these, 234 patients (44.8%) had non-keratinizing squamous cell carcinoma (NKSCC), while 106 patients (20.3%) were diagnosed with keratinizing squamous cell carcinoma (KSCC). Additionally, basal cell carcinoma (BCC) was found in 182 patients (34.9%).

Results: Combination therapy was utilized in several ways: telegamma therapy (TGT) combined with polychemotherapy (PCT) was used in 41 cases (7.8%); PCT combined with TGT was used in 9 cases (1.7%); and TGT combined with surgery was used in 64 cases (12.3%). Multimodal therapy was also administered in different combinations: TGT, surgery, and TGT together were used in 98 cases (18.8%), while TGT, surgery, and PCT were used in 51 cases (9.8%). TGT alone was administered to 244 patients (46.7%). Out of the total number of patients with cutaneous LSC observed, 168 patients (32.2%) reported subjective improvements, and 158 patients (30.3%) showed objective improvements in their condition. This indicates that radiation therapy was effective for 326 out of 522 patients, or 62.5%.

Conclusion: The results indicated that treating cutaneous LSC requires a multimodal approach. Radiation therapy can be utilized in various ways and serves as a key component of specialized treatment. When appropriately administered, palliative radiation therapy for advanced skin cancer can alleviate symptoms and complications, thereby enhancing patients' quality of life.

Keywords: Skin cancer, stages of skin cancer, metastases, basal cell and squamous cell skin cancer, radiation therapy, combined and multimodal treatment.

Download file:


References
  1. Shulaev AV, Zaripova RN, Zhaboeva SL. Rasprostranyonnost' faktorov riska raka kozhi i upravlenie imi (obzor literatury) [Prevalence and management of skin cancer risk factors (literature review)]. Obshchestvennoe zdorov'e i zdravookhranenie. 2020:2;11-7.
  2. Shlyakhtunov EA, Gidranovich AV, Lud NG, Lud LN, Kozhar VL, Proshokin AV. Rak kozhi: sovremennoe sostoyanie problemy [Skin cancer: Current state of the problem]. Vestnik VGMU. 2014;13(3):20-8.
  3. Zdorov'e naseleniya i zdravookhranenie v Respublike Tadzhikistan v 2021 godu Sbornik. [Population health and healthcare in the Republic of Tajikistan in 2021]. Dushanbe, RT: Devashtich; 2022. 356 p.
  4. Sayfutdinova MB, Zikiryakhodzhaev DZ, Yuldoshev RZ. Vklad uchyonykh Tadzhikistana v reshenii problemy diagnostiki i lecheniya raka kozhi [The contribution of Tajikistan scientists to solving the problems of diagnosis and treatment of skin cancer]. Simurg. 2023;3:33-7.
  5. Zhilova MB, Butareva MM. UF-izluchenie kak faktor riska nemelanomnogo raka kozhi. Geneticheskie determinanty onkogeneza [UV radiation as a risk factor for non-melanoma skin cancer. Genetic determinants of tumorigenesis]. Vestnik RAMN. 2018;73(5):306-13. https://doi.org/10.15690/vramn941
  6. Zikiryakhodzhaev DZ, Sayfutdinova MB, Orifov BM. Osobennosti raka kozhi, razvyvshegosya v oblasti rubtsovykh izmeneniy: obzor literatury [Features of skin cancer that has developed in the area of scarring: A review of the literature]. Sarkomy kostey, myagkikh tkaney i opukholi kozhi. 2022;14(1):25-32. https://doi. org/10.17650/2782-3687‑2022‑14‑1‑25‑32
  7. Zikiryakhodzhaev AD, Orifov BM, Zikiryakhodzhaev DZ, Khuseynov ZKh, Yuldoshev RZ. Kliniko-morfologicheskie osobennosti i lechenie raka kozhi, razvyvshegosya iz rubtsov [Clinical and morphological features and treatment of skin cancer that has developed from scars]. Vestnik Avitsenny [Avicenna Bulletin]. 2014;1:38-42.
  8. Abramova OE, Kudryavtsev DV, Gumenetskaya YuV. Opyt primeneniya luchevoy terapii v kombinirovannom lechenii bazal'nokletochnogo raka kozhi zatylochnoy oblasti s metastazom v regionarnyy limfaticheskiy uzel [Experience in the use of radiation therapy in the combined treatment of basal cell skin cancer of the occipital region with metastasis to the regional lymph node]. Radiatsiya i risk. 2020;29(4):126-35. https://doi.org/10.21870/0131-3878-2020-29-4-126-135
  9. Sayfutdinova MB. Rol' luchevoy terapii v lechenii raka kozhi rannikh stadiy [The role of radiation therapy in the treatment of early stage skin cancer]. Sarko- my kostey, myagkikh tkaney i opukholi kozhi. 2023;15(4):19-24. https://doi. org/10.17650/2782-3687-2023-15-4-19-24
  10. Khansen EK (red.) Luchevaya terapiya v onkologii. per. s angl. 2-e izd. [Radiation therapy in oncology]. Moscow, RF: GEOTAR-Media; 2023. 984 p.
  11. Gevorkov AR, Boyko AV, Polyakov AP, Chernichenko AV, Gerasimov VA, Meshcheryakova IA, i dr. Luchevaya terapiya ploskokletochnogo raka kozhi: sovremennye standarty i dal'neyshie perspektivy [Radiation therapy for squamous cells skin cancer: Modern standards and future prospects]. Opukholi golovy i shei. 2022;12(3):53-70. https://doi.org/10.17650/2222-1468-2022-12- 3-53-70
  12. Mierzwa ML. Radiotherapy for skin cancers of the face, head, and neck. Fa- cial Plast Surg Clin N Am. 2019;27(1):131-8. https://doi.org/10.1016/j. fsc.2018.08.005
  13. Madorsky SJ, Meltzer Orr A, Miller A. Superficial radiotherapy: long term follow- up of highly selected basal and squamous cell carcinomas in skin cancer patients. Skin Cancer and Reconstructive Surgery Center (SCARS Center) at 180 Newport Center Drive, Suite 158, Newport. J Dermatol & Skin Sci. 2022;4(4):1-5.
  14. Ivanov SA, Achinovich SL, Ivanova OV. Pyatiletnie rezul'taty lecheniya raka kozhi nosa razlichnymi metodami [Five-year results of treatment of nasal skin cancer using various methods]. Evraziyskiy onkologicheskiy zhurnal. 2023;11(3):188-97. htpps://doi.org/10.34883/PI.2023.11.3.019
  15. Pashazadeh A, Boese А, Friebe М. Radiation therapy techniques in the treatment of skin cancer: An overview of the current status and outlook. J Dermatol Treat. 2019;30(8):831-9. htpp://doi.org/10.1080/09546634.2019.1573310
  16. Zhu S, Sun C, Zhang L, Du X, Tan X, Peng S. Incidence trends and survival prediction of malignant skin cancer: A SEER-based study. Int J Gen Med. 2022;15:2945-56. https://doi.org/10.2147/IJGM.S340620
  17. Jilani OK, Singh P, Wernicke AG, Kutler DI, Kuhel W, Christos P, et al. Radiation therapy is well tolerated and produces excellent control rates in elderly patients with locally advanced head and neck cancers. J Geriatr Oncol. 2012;3(4):337-43. https://doi.org/10.1016/j.jgo.2012.05.001

Authors' information:


Sayfutdinova Munfiza Burkhonovna,
Candidate of Medical Sciences, Associate Professor, Head of the Department of Roentgenology and Radiology, Avicenna Tajik State Medical University
Researcher ID: KBA-2116-2024
Scopus ID: 58513181800
ORCID ID: 0009-0000-5083-1863
SPIN: 1164-1158
Author ID: 1099069
E-mail: munfiza.sayfutdinova@mail.ru

Zikiryakhodzhaev Dilshod Zukirovich,
Doctor of Medical Sciences, Full Professor, Vice President for International Relations, Association of Directors of Oncology and Radiology Centers and Institutes of the CIS
Researcher ID: KHX-4304-2024
ORCID ID: 0009-0006-0402-911X
SPIN: 8347-6047
Author ID: 1242743
E-mail: firuzik49@mail.ru

Nazarov Shokhin Kuvvatovich,
Doctor of Medical Sciences, Gull Professor, Head of the Department of Surgical Diseases No. 1 named after Akademician K.M. Kurbоnov, Avicenna Tajik State Medical University
Scopus ID: 57216884240
ORCID ID: 0000-0003-2099-2353
SPIN: 1817-7089
Author ID: 845034
E-mail: shohin67@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Sayfutdinova Munfiza Burkhonovna
Candidate of Medical Sciences, Associate Professor, Head of the Department of Roentgenology and Radiology, Avicenna Tajik State Medical University

734026, Republic of Tajikistan, Dushanbe, Sino str., 29-31

Tel.: +992 (918) 665261

E-mail: munfiza.sayfutdinova@mail.ru


This work is licensed under a Creative Commons Attribution 4.0 International License.

Materials on the topic: